By far the most common variant of CTCL is mycosis fungoides and its leukemic variant Sézary syndrome. Mycosis fungoides imposes a tremendous physical as well as psychological burden for patients ...

High-potency Class I to II topicals are frequently used first line to suppress inflammation and symptoms of itching. These agents are often useful as therapy for stage IA disease, but are often ...